The House Human Services Committee meeting on January 9, 2025, focused on addressing substance use during pregnancy and its implications for maternal and child health. A significant concern raised was the increasing rates of illicit drug use among pregnant women, with a 2020 national survey indicating that 8% reported recent drug use. The meeting highlighted the associated risks, including preterm births and severe maternal health issues.

A key discussion point was the fear among pregnant women regarding mandated reporting laws, which can lead to the loss of custody of their children if they seek medical help for substance use disorders (SUD). This fear acts as a barrier to treatment, as evidenced by research showing that states with less stringent reporting policies see higher rates of treatment admissions for pregnant individuals. The proposed bill aims to alleviate these fears, encouraging women to seek necessary medical care without the threat of losing their children.

Additionally, the committee discussed the importance of extending support to postpartum women, who may experience a recurrence of substance use issues within the first year after childbirth. The meeting referenced recent legislative changes that extended Medicaid coverage for postpartum care from six weeks to twelve months, emphasizing the need for ongoing support for mental health and substance use treatment during this critical period.

The committee expressed strong support for the bill, recognizing its potential to improve health outcomes for both mothers and their children. The discussions underscored the need for thoughtful policy changes that prioritize the well-being of families and remove barriers to accessing care. The meeting concluded with an invitation for questions, highlighting the collaborative effort to address these pressing health concerns.